Expertise in
13
conditions

Dr. Zoe Draelos

Dermatology
Office
2444 N Main St, 
High Point, NC 
Expertise in
13
conditions
Office
2444 N Main St, 
High Point, NC 

Overview

Zoe Draelos is a Dermatologist in High Point, North Carolina. Dr. Draelos is highly rated in 13 conditions, according to our data. Her top areas of expertise are Acne, Rosacea, Pustules, and Atopic Dermatitis.

Her clinical research consists of co-authoring 280 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Dermatology

Licenses

Dermatology in NC

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Office
2444 N Main St, High Point, NC 27262

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
Enrollment Status: Completed
Publish Date: September 07, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris
A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris
Enrollment Status: Completed
Publish Date: December 16, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Single-center, Placebo Controlled Study to Investigate the Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults
A Single-center, Placebo Controlled Study to Investigate the Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults
Enrollment Status: Completed
Publish Date: July 09, 2020
Intervention Type: Other, Dietary supplement
Study Phase: Not Applicable
A Multi-center,Double-blind,Randomized,Three-arm,Placebo-controlled,Parallel-group Study, Comparing Dapsone Gel,7.5% (Torrent Pharma) to Aczone® Gel,7.5% and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
A Multi-center,Double-blind,Randomized,Three-arm,Placebo-controlled,Parallel-group Study, Comparing Dapsone Gel,7.5% (Torrent Pharma) to Aczone® Gel,7.5% and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Enrollment Status: Completed
Publish Date: April 02, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Enrollment Status: Completed
Publish Date: June 04, 2019
Intervention Type: Other, Biological
Study Phase: Phase 2
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea
Enrollment Status: Completed
Publish Date: June 21, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 11 Less Clinical Trials

280 Total Publications

Long-term efficacy and tolerability of clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for acne: pooled results from two 6-month studies.
Long-term efficacy and tolerability of clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for acne: pooled results from two 6-month studies.
Journal: The Journal of dermatological treatment
Published: January 19, 2026
Similar Doctors
Expertise in
23
conditions
Dr. Amy Mcmichael
Dermatology
Expertise in
23
conditions
Dr. Amy Mcmichael
Dermatology

Atrium Health Wake Forest Baptist Dermatology-Country Club

4618 Country Club Rd, 
Winston Salem, NC 
 (18.3 miles away)
336-716-3926
Languages Spoken:
English
See accepted insurances

Amy Mcmichael is a Dermatologist in Winston Salem, North Carolina. Dr. Mcmichael is highly rated in 23 conditions, according to our data. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Alopecia Areata, Graham-Little-Piccardi-Lassueur Syndrome, and GAPO Syndrome.

Daniela Kroshinsky
Expertise in
19
conditions
Dr. Daniela Kroshinsky
Dermatology
Expertise in
19
conditions
Dr. Daniela Kroshinsky
Dermatology

Duke Pediatric Dermatology Patterson Place

5324 McFarland Rd, 
Durham, NC 
 (57.8 miles away)
919-401-7733
Experience:
23+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniela Kroshinsky is a Dermatologist in Durham, North Carolina. Dr. Kroshinsky has been practicing medicine for over 23 years is highly rated in 19 conditions, according to our data. Her top areas of expertise are Calciphylaxis, Cellulitis, Calcinosis, and Acute Febrile Neutrophilic Dermatosis.

Expertise in
61
conditions
Dr. Joseph Jorizzo
Dermatology
Expertise in
61
conditions
Dr. Joseph Jorizzo
Dermatology

Atrium Health Wake Forest Baptist Dermatology-Country Club

4618 Country Club Rd, 
Winston Salem, NC 
 (18.3 miles away)
336-716-3926
Languages Spoken:
English
See accepted insurances

My passion throughout my career in dermatology has been to care for adult and pediatric patients with complex medical dermatology problems. My research and publications focus on dermatologic manifestations of internal medical diseases. I also care for patients with common dermatologic problems of skin, hair, nails, and mucous membranes. Dr. Jorizzo is highly rated in 61 conditions, according to our data. His top areas of expertise are Pyoderma Gangrenosum, Lichen Planus, Cutaneous Lupus Erythematosus (CLE), and Dermatomyositis.

Frequently Asked Questions about Dr. Zoe Draelos

How do I make an appointment with Dr. Zoe Draelos?

You can book an appointment with Dr. Zoe Draelos by calling their office at 336-841-2040. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Zoe Draelos a top-rated expert for Acne?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Zoe Draelos is classified as an Elite expert for Acne, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Zoe Draelos specialize in?

While Dr. Zoe Draelos is a Dermatology, they have specific expertise in Acne, Rosacea, and Pustules. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Zoe Draelos participate in research or clinical trials?

Yes. Dr. Zoe Draelos has published 280 articles and abstracts on conditions like Acne. You can view a list of Dr. Zoe Draelos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Zoe Draelos accept my insurance?

Dr. Zoe Draelos accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 336-841-2040 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Draelos's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile